Lupiximab 500 mg Injection
  1. Home
  2. Pharma Products
  3. Lupin Ltd
  4. Lupiximab 500 mg Injection

Lupiximab 500 mg Injection

Lupiximab 500 mg Injection contains rituximab 500 mg, a monoclonal antibody that targets CD20-positive B cells. It is used for certain blood cancers such as non-Hodgkin lymphoma and chronic lymphocytic leukemia, as well as selected autoimmune conditions. The medicine is administered by intravenous infusion under the supervision of a healthcare professional.

BUY NOW

Category

Rituximab works by binding to the CD20 protein on B cells and helping the immune system remove these cells. It may be used alone or with other medicines depending on the condition and prescribed treatment protocol. Patients require monitoring during treatment because infusion reactions, infections, and changes in blood-cell counts can occur. The dosage and treatment schedule are individualized by the treating specialist according to the patient’s condition and clinical response.

Technical Specification

Specification Details
Active Ingredient Rituximab
Strength 500 mg
Concentration 10 mg/mL
Dosage Form Solution for Injection
Route of Administration Intravenous Infusion
Pack Size 1 Vial, 50 mL

Product Also Known As

Lupiximab 500 mg Injection, Lupiximab 500mg Injection, Lupiximab 500 mg Vial, Lupiximab 500mg Vial, Rituximab 500 mg Injection, Rituximab 500mg Injection, Rituximab 500 mg Vial